Skip to main content

Table 3 Analysis of observation indexes (except for patients with > 50% articular surface involvement)

From: ‘Triple clear’: a systematic and comprehensive surgical process for Campanacci grades II and III giant cell tumors of the bone, with or without pathological fracture and slight joint invasion

Variable

SR group

( n =24)

TC group

( n =41)

P -value

VAS* score

pre-operation

3.8±1.1

3.3±1.0

0.100

post-operation

1.7±0.8

1.6±0.9

0.722

MSTS* score

three months post-operation

18.8±1.3

19.8±1.5

0.010 ( P <0.05)

two years post-operation

24.3±1.4

26.2±1.2

0.000 ( P <0.05)

recurrence, n (%)

2 (8.3%)

3(7.3%)

0.882

Recurrence, n (before 2017)

1(15)

2(20)

0.727 (P’=0.703)

Recurrence rate (before 2017)

6.7%

10.0%

 

Recurrence,n (after 2017)

1(9)

1(21)

0.523 (P’’=0.520)

Recurrence rate (after 2017)

11.1%

4.8%

 

Reoperation, n (%)

4

3

0.241

Complications, n (%)

prosthesis loosening

2

0

0.060

infection

0

1

1.000

Postoperative satisfaction

24

40

0.040 ( P <0.05)

  1. *VAS Visual analogue score, MSTS Musculoskeletal tumor society
  2. P’: Describe the statistical differences in recurrence rates in the SR group before and after 2017
  3. P’’: Describe the statistical differences in recurrence rates in the TC group before and after 2017